Dynavax Technologies Corporation Archives - BioPharmaJournal

Home Tags Dynavax Technologies Corporation

Dynavax Technologies Corporation (NASDAQ:DVAX) Reports Record HEPLISAV-B® Vaccine Net Revenue Of...

Matt Wade - November 13, 2020 0

Dynavax Technologies’(NASDAQ:DVAX) Appoints Peter Paradiso To Board And Its CFO To...

Gavins Felicity - October 1, 2020 0

The Bill & Melinda Gates Foundation Grants Dynavax Technologies Corporation (NASDAQ:DVAX)...

Kate Hudson - August 19, 2020 0

TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...

Gavins Felicity - August 13, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Collaboration with Mount Sinai to Develop a...

Kate Hudson - July 23, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Partners with Medicago to Investigate and Evaluate...

Matt Wade - July 16, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Completes Enrolment IN Study Evaluating Hepatitis B...

Gavins Felicity - June 23, 2020 0

Recent Post

Invesco QQQ Trust Series 1 (QQQ) hits all time high and...

Kate Hudson - June 5, 2023 0

The QQQ’s made new 12 month highs again this morning, continuing to grind higher ahead of the FED meeting next week.

Banking stocks in focus

Stocks In focus ahead as Wall Street grows hopeful of a...

May 26, 2023

Best Stocks Alerts

Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3...

May 3, 2023

IPOs are starting to heat up again (TRNR,GNLX,TCJH)

May 1, 2023

TOP Financial Group Limited ($TOP) surges over 600% after market hours

April 27, 2023